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Intraductal papillary neoplasm of the bile duct (IPNB) is classified as a biliary cystic tumor with a tendency of causing
obstruction. Neoplastic cases involving hemobilia are rarely reported. We herein describe a case of biliary cystic tumor
with repeated hemobilia. A 57-year-old woman was histologically diagnosed with cavernous hemangioma. During the
follow-up period after transcatheter arterial embolization (TAE), she experienced repeated hemobilia, and multiple other
TAE sessions were performed for hemostasis. She was referred to our hospital 8 years after the first surgery owing to a
growing tumor. Histopathological examination after extended right hepatectomy and caudate lobectomy indicated
IPNB with an associated invasive carcinoma. Six months thereafter, computed tomography revealed a recurrent liver
tumor and a nodule in the abdominal cavity. She died 36 months after the second surgery, despite chemotherapy. Our
experience suggests that IPNB should be considered during differential diagnosis of dilated hepatobiliary tumors with
hemobilia.
Keywords: Hemobilia; Biliary cystic tumor; IPNBBackground
Hemobilia is usually caused by trauma, iatrogenic
events, cholangitis, and cholelithiasis, but rarely associ-
ated with a tumor [1]. On the other hand, biliary cystic
tumors are rare neoplasms arising in the liver and extra-
hepatic biliary system at a lower frequency [2]. The latest
World Health Organization (WHO) Classification of
Tumors of the Digestive System published in 2010 codi-
fied and defined hepatic mucinous cystic neoplasms
(MCN) and intraductal papillary neoplasms of the bile
duct (IPNB) as the counterparts of pancreatic MCN and
intraductal papillary mucinous neoplasm (IPMN-P) [3].
IPNB is identified as a premalignant lesion or intrae-
pithelial neoplasm of the bile duct, and it is relatively
rare among all bile duct cancers. Here, we report a case
of biliary cystic tumor with repeated hemobilia that was
followed up for 8 years. We also present its histological
characteristics and discuss relevant literature.* Correspondence: df26@smn.enjoy.ne.jp
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A 57-year-old woman was previously admitted to a
hospital because of abdominal pain. Gastrointestinal
fiberscopy showed hemobilia, whereas abdominal ultra-
sonography and computed tomography (CT) performed
at the time showed two tumors in the liver: one in the
lateral segment measuring 4 × 3 cm in diameter and the
other in the posterior segment measuring 10 × 5 cm in
diameter. CT showed no clear differences between the
two tumors; they were multiple capsulated lesions filled
with cystic contents and highly enhanced mural nodules
(data not shown). Additionally, the needle biopsy for
both tumors did not reveal a malignant finding - a frag-
ment of liver tissue with no malignancy. Despite the
tumors being thought as benign, she underwent a diag-
nostic partial resection of the lateral segment. Histo-
logical examination indicated cavernous hemangioma.
She then received transcatheter arterial embolization
(TAE) for hemostasis of the right lobe tumor. During
the follow-up period thereafter, she experienced six epi-
sodes of hemobilia, and four other TAE sessions were
performed. She was referred to our hospital 8 years after
the diagnostic surgery owing to the growing tumor in
the right lobe.is an open access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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tomy at 9 years of age, Cesarean section at the age of 26
and 29 years, and right lower lobectomy with partial re-
section of the lungs' left upper lobe for adenocarcinomas
at the age of 53 years. She had no history of liver disease,
including hepatolithiasis.
Laboratory results on admission were as follows:
hemoglobin, 11.1 g/dL; total bilirubin, 0.5 mg/dL; aspar-
tate aminotransferase, 65 IU/L; alanine aminotransferase,
54 IU/L; alkaline phosphatase, 819 IU/L; and γ-glutamyl
transpeptidase, 227 IU/L. Levels of alpha-fetoprotein
and protein induced by vitamin K absence were within
normal limits, while those of carcinoembryonic antigen
and carbohydrate antigen 19–9 were elevated to
12.8 ng/mL and 862 U/mL, respectively. Viral markers
for hepatitis B and C were negative.
On physical examination of the abdomen, the liver
edge was palpable four fingerbreadths beneath the xiph-
oid process. Abdominal ultrasonography revealed a mul-
tilocular oval mass with papillary infolding measuring
10 × 15 cm located in the right hepatic lobe. CT scans
showed a low-density hepatic tumor measuring 15 cm in
diameter that occupied almost the entire right andb
a
Figure 1 Abdominal contrast computed tomography (post-transcathe
findings. (a) Computed tomography scan showed a low-density hepatic le
were contrast-enhanced. The TAE coils were observed. (b) T1-weighted
(c) T2-weighted image demonstrated high signals from the mural noducaudal lobes, compressing the portal vein. The nodules
were contrast-enhanced (Figure 1a). T1-weighted mag-
netic resonance imaging showed a low-intensity mass,
except for the mural nodules. The signals from these
mural nodules were high on T2-weighted images
(Figure 1b,c). A superior mesenteric arteriography
showed the right hepatic artery originating from the su-
perior mesenteric artery with the tumor stain present
(Figure 2). Fluorodeoxyglucose positron emission tom-
ography/CT showed high tumor uptake.
Endoscopic retrograde cholangiography demonstrated
obstruction of the right hepatic bile duct, compression
of the left hepatic duct, and dilatation of the peripheral
bile ducts (Figure 3). The cystic lesion was suspected as
a mucin-producing liver tumor, such as MCN of the
liver or IPNB. Biliary cytology was diagnosed as papillary
adenocarcinoma in situ or papillary adenoma with se-
vere atypia.
The patient underwent right hemihepatectomy
(stipulate + Sg1) with cholecystectomy and concurrent
splenectomy owing to the growing aneurysm of the
splenic artery. Macroscopic observation indicated a
direct connection between the cystic lesion and thec
ter arterial embolization [TAE]) and magnetic resonance imaging
sion measuring 15 cm in diameter with mural nodules. These nodules
image showed a low-intensity mass, except for the mural nodules.
les.
Figure 2 Transcatheter arterial embolization sequence as
shown in a right hepatic angiography. The angiography also
demonstrated hypervascular lesions in the cystic tumor.
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gated bile ducts and gave attention not to spill bile
into the abdominal cavity. The resected multilocular
tumor was filled with clear mucus, and the cut sur-
face showed multiple yellowish papillary nodules lin-
ing the cystic wall. The cyst had a direct luminal
communication with the right hepatic duct. Histo-
logical examination indicated the biliary cystic lesion
was a well-differentiated adenocarcinoma (Figure 4).
Ovarian-like stroma was not evident. Thus, the final
diagnosis was IPNB with an associated invasive carcinoma.Figure 3 Endoscopic retrograde cholangiography findings.
Endoscopic retrograde cholangiography showed obstruction of the
right hepatic bile duct, compression of the left hepatic duct, and
dilatation of the peripheral bile ducts.The patient was discharged 51 days after surgery, despite
experiencing cholangitis and enteritis previously during the
post-operative course.
Six months after surgery, CT scans revealed a recur-
rent liver tumor and a nodule in the abdominal cavity.
Unfortunately, the patient died 36 months after surgery,
despite chemotherapy.
Discussion
Hemobilia was first reported by Sandblom in 1948. It is
a rare condition often caused by trauma, iatrogenic
events, cholangitis, or cholelithiasis [1], but rarely by
neoplasms (5% to 6% of all cases) [4]. Its symptom is
known as the trilogy of Quincke, upper gastrointestinal
hemorrhage, epigastralgia, and jaundice. When the bil-
iary tract is obstructed by blood clots, abdominal pain
and jaundice occur because of increased pressure in the
tract. In the presented case, our patient experienced ab-
dominal pain, but not jaundice, and her laboratory re-
sults indicated anemia with abnormal liver function.
Angiography is recommended for the examination and
treatment of uncontrolled hemobilia [5]. If hemorrhage
occurs from an artery, TAE is the first choice of treat-
ment and often effective. Although our patient was suc-
cessfully treated with TAE for the six hemobilia episodes
during her 8-year hemangioma follow-up, hemorrhage
recurred frequently, and the tumor was growing. She
therefore underwent surgical intervention and was fi-
nally diagnosed with IPNB and an associated invasive
carcinoma.
Common symptoms and complications of IPNB are
abdominal pain, liver function disorder, jaundice, or
fever caused by the bile duct obstruction due to hyperse-
cretion of mucin or the tumor itself [6,7]. We could not
find a previous report of hemobilia caused by IPNB by
searching MEDLINE using the English language. Suga-
wara et al. suggested that the risk of hemobilia from
neoplasms depended on tumor size and histological
type, especially in cases of soft and fragile papillary tu-
mors [8]. Biliary cystic tumors are rare neoplasms occur-
ring in the liver and, less frequently, the extrahepatic
biliary system [2]. They account for less than 5% of all
reported cystic lesions of the liver [9].
According to the 2010 WHO Classification of Tumors
of the Digestive System, biliary cystic tumors are no lon-
ger defined as biliary cystadenoma, papillomatosis, papil-
lary adenocarcinoma, or biliary cystadenocarcinoma, but
instead are redefined as IPNB and MCN of the liver [3].
IPNB is identified as a premalignant lesion or intrae-
pithelial neoplasm of the bile duct and divided into
intraductal papillary neoplasms with low-, intermediate-,
or high-grade intraepithelial neoplasia, according to
tumor cell grade [7,10]. Papillary tumors of the bile duct
are relatively rare with a reported prevalence of 4% to
a b
Figure 4 Macroscopic and histopathological findings from the resected specimens. (a) The cut surface of the resected specimen showed a
multilocular cystic lesion with many papillary nodules projecting from the lining wall, as well as transparent mucinous fluid. (b) The tumor was
histologically composed of a well-differentiated adenocarcinoma with papillary structures. The cyst wall was lined with thick hyalinized connective
tissue, and stromal invasion of the tumor was observed (hematoxylin and eosin stain, ×100).
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hand, MCN of the liver is the biliary counterpart of pan-
creatic MCN. The disease usually occurs in women and
does not exhibit a luminal communication with the pan-
creatic or bile ducts [14]. MCN also differs from IPNB
with respect to the expression of estrogen and progester-
one receptors, owing to the presence of a subepithelial
ovarian-like stroma in the former. In this case, the intra-
hepatic bile ducts were markedly dilated with papillary
proliferation in the lumen, and the tumor cells exhibited
marked atypical appearance. Ovarian-like stroma was
not identified. Thus, our final diagnosis was IPNB with
an associated invasive carcinoma.
Ogawa et al. reported several CT findings of IPNB
[15], including the presence of intraductal mass, exten-
sive infiltration along the bile duct, intense enhancement
rim at the base of the mass, and isodense or hyperdense
lesions relative to the normal hepatic parenchyma during
the late arterial phase. In our case, the tumor was en-
hanced from the portal to the venous phase with ob-
struction of the right hepatic bile duct. Although
hemangioma, which was our preoperative diagnosis,
could also exhibit a tendency of volume increasing and
contrast enhancement as a result of bleeding, the
resected tumor in this case presented as a multilocular
cyst filled with multiple yellowish papillary nodules, hy-
persecretion of clear mucin, and granular mucosa grow-
ing directly into the bile duct lumen. As also observed in
IPMN-P, columnar and cuboidal tumor cells of IPNB
have papillary or villous structures and show expansive
growth into the lumen of the bile duct with fibrous vas-
cular stroma.
The CT findings in our case showed well-enhanced
massive papillary contents in the dilated bile ducts with
extravasation. The intraductal papillary contents evident
by contrast CT further indicated that the tumor waspresent in the bile ducts instead of the liver parenchyma.
Moreover, the repeated hemobilia episodes were also in-
dicative of the bile ducts' involvement.
IPNB are recognized as slow-growing neoplasms
compared to normal intrahepatic bile duct carcinoma
[16]. Several articles present and recommend radical
surgical management as the first choice of treatment
for IPNB [6,17], with a reported 5-year survival rate
after radical surgery ranging from 31% to 80% [18].
But in a latest big study, Kubota et al. reported bet-
ter prognosis of resected IPNB [7]. They emphasize
the necessity of complete resection, and the 1-, 3-, 5-,
and 10-year overall survival rates for the 105 mucin-
producing IPNB patients were 96%, 90.4%, 84%, and
81.1%. If a recurrent tumor is present, radical surgical
therapy must be planned owing to its slow growing char-
acteristic [6].
In this case, only the lateral lesion was resected for
diagnostic purposes in the initial surgery, owing to the
lack of any malignant impression. The residual lesion in
the right lobe showed slow progression, with repeated
hemobilia. IPNB also exhibits slow clinical progression,
despite the possibility of direct invasion to the bile duct,
leading to its dilatation, jaundice, or hemobilia.
Conclusions
Our case presented a thought-provoking hepatobiliary
course. The patient was initially followed for a slow-
growing hepatic hemangioma, but eventually diagnosed
with IPNB. It was challenging to distinguish the two
conditions. Furthermore, although there are several re-
ports of hemobilia originating from hepatic hemangioma,
it is very rare in IPNB. Nonetheless, our experience in
this case suggests that IPNB should be considered during
differential diagnosis of dilated hepatobiliary tumors with
hemobilia.
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